Risk Factors for Locoregional Failure in Patients With Inflammatory Breast Cancer Treated With Trimodality Therapy
Authors:
- Judith HurleyJHJudith Hurley
- Cristiane TakitaCTCristiane Takita
- Isildinha M. ReisIRIsildinha M. Reis
- Wei ZhaoWZWei Zhao
- Steven E. RodgersSRSteven E. Rodgers
- Jean L. WrightJWJean L. Wright
- 1 October 2013
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 13 (5) , 335-343
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Modern Outcomes of Inflammatory Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Dermal Lymphatic Invasion and Inflammatory Breast Cancer Are Independent Predictors of Outcome After Postmastectomy RadiationAmerican Journal of Clinical Oncology, 2009
- Locoregional Treatment Outcomes After Multimodality Management of Inflammatory Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer InstituteJNCI: Journal of the National Cancer Institute, 2005
- Radiothérapie hyperfractionnée accélérée alternée avec une chimiothérapie dans le cancer du sein inflammatoire non métastatiqueCancer/Radiothérapie, 2000
- Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinomaAnnals of Surgical Oncology, 1997
- Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapyCancer, 1995
- Multimodal treatment for inflammatory breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Inflammatory cancer of the breast: Analysis of 114 casesJournal of Surgical Oncology, 1981